Copyright
©The Author(s) 2019.
World J Diabetes. Jan 15, 2019; 10(1): 47-56
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.47
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.47
Table 1 Demographic, anthropometric and clinical characteristics of the study subjects n (%)
Variables | DM, n = 85 | HC, n = 85 | P-value |
Age (yr) | |||
mean ± SD1 | 61.7 ± 11.1 | 60.9 ± 10.3 | 0.620 |
< 50 yr | 11 (12.9) | 11 (12.9) | 0.965 |
50-59 yr | 25 (29.4) | 27 (31.8) | |
60-69 yr | 22 (25.9) | 23 (27.1) | |
≥ 70 yr | 27 (31.8) | 24 (28.2) | |
Gender | |||
Male | 44 (51.8) | 44 (51.8) | 1.000 |
Female | 41 (48.2) | 41 (48.2) | |
Height (m)1 | 1.66 ± 0.08 | 1.65 ± 0.08 | 0.473 |
Weight (Kg)1 | 71.3 ± 13.6 | 65.4 ± 11.5 | 0.003 |
BMI (Kg/m2)1 | |||
mean ± SD1 | 26.0 ± 5.3 | 24.1 ± 4.3 | 0.010 |
Underweight | 3 (3.5) | 4 (4.7) | 0.072 |
Normal BMI | 35 (41.2) | 51 (60.0) | |
Overweight | 31 (36.5) | 21 (24.7) | |
Obese | 16 (18.8) | 9 (10.6) | |
Systolic BP (mmHg)1 | 129.8 ± 20.7 | 131.9 ± 24.3 | 0.557 |
Diastolic BP (mmHg)1 | 84.2 ± 11.5 | 82.8 ± 13.1 | 0.404 |
Total cholesterol (mmHg)1 | 4.90 | 4.78 | 0.622 |
FBG (mmol/L)1 | 7.00 ± 2.16 | 5.15 ± 0.06 | 0.001 |
HbA1C in % (mean ± SD) | 8.69 ± 2.46 | - | - |
Duration of DM in months median (range) | 48.0 (0.3-312) | - | - |
Peripheral neuropathy | 51 (60) | - | - |
Table 2 Comparison of median nerve cross-sectional area between diabetics and healthy controls
Median nerve CSA (mm2) | DM, n = 85 | HC, n = 85 | P-value | |
Right | Carpal tunnel | 12.5 ± 2.5 | 8.8 ± 1.7 | < 0.01 |
5 cm proximal | 8.0 ± 2.0 | 5.3 ± 1.2 | < 0.01 | |
Left | Carpal tunnel | 12.3 ± 2.5 | 8.6 ± 1.7 | < 0.01 |
5 cm proximal | 7.9 ± 1.9 | 5.4 ± 1.4 | < 0.001 |
Table 3 Comparison of median nerve cross-sectional area between diabetics with and diabetics without diabetic peripheral neuropathy
Median nerve CSA (mm2) | Diabetic peripheral neuropathy | P-value | |
Absent n = 34 | Present n = 51 | ||
Carpal tunnel | 11.8 ± 2.4 | 12.9 ± 2.5 | 0.049 |
5cm Proximal | 8.0 ± 2.2 | 8.0 ± 2.0 | 0.856 |
Table 4 Comparison of median nerve cross-sectional area between diabetics without diabetic peripheral neuropathy, diabetics with mild diabetic peripheral neuropathy and diabetics with moderate/severe diabetic peripheral neuropathy
Median nerve CSA (mm2) | Peripheral neuropathy | P-value | ||
Absent (n = 34) | Mild (n = 32) | Moderate/severe (n = 19) | ||
Carpal tunnel | 11.8 ± 2.4a | 13.2 ± 2.6a | 12.3 ± 2.1a | 0.062 |
5 cm Proximal | 7.9 ± 2.2b | 8.3 ± 2.2b | 7.6 ± 1.4b | 0.145 |
Table 5 Comparison of median nerve cross-sectional area between categories of age, gender, duration of diabetes mellitus, and glycemic control at carpal tunnel and 5 cm proximal to the carpal tunnel
Median nerve CSA (mm2) at CATL | |||||||
DM_nonDPN | P-value | DM_DPN | P-value | HC | P-value | ||
Duration of DM | ≤ 5 yr | 11.4 ± 1.8 | 0.65 | 12.9 ± 2.4 | 0.99 | - | - |
> 5 yr | 11.8 ± 3.3 | 12.9 ± 2.7 | - | ||||
FBG | ≤ 7 mmol/L | 11.6 ± 2.3 | 0.79 | 13.2 ± 2.9 | 0.34 | - | - |
> 7 mmol/L | 11.4 ± 2.0 | 12.5 ± 1.8 | - | ||||
HBA1c | ≤ 7% | 11.0 ± 1.8 | 0.45 | 12.3 ± 2.4 | 0.20 | - | - |
> 7% | 11.7 ± 2.3 | 13.2 ± 2.6 | - | ||||
Age | ≤ 60 yr | 11.1 ± 1.9 | 0.25 | 12.9 ± 2.3 | 1.00 | 8.7 ± 1.5 | 0.37 |
> 60 yr | 12.0 ± 2.4 | 12.9 ± 2.7 | 8.4 ± 1.9 | ||||
Sex | Female | 11.3 ± 1.9 | 0.62 | 13.2 ± 2.6 | 0.42 | 8.1 ± 1.2 | 0.02 |
Male | 11.7 ± 2.4 | 12.6 ± 2.4 | 9.0 ± 2.0 | ||||
Median nerve CSA (mm2) at 5cmCATL | |||||||
DM_nonDPN | P-value | DM_DPN | P-value | HC | P-value | ||
Duration of DM | ≤ 5 yr | 7.6 ± 1.9 | 0.87 | 7.7 ± 1.7 | 0.13 | - | - |
> 5 yr | 7.5 ± 1.5 | 8.5 ± 2.2 | - | ||||
FBG | ≤ 7 mmol/L | 7.5 ± 1.3 | 0.74 | 8.2 ± 1.9 | 0.57 | - | - |
> 7 mmol/L | 7.7 ± 2.5 | 7.9 ± 2.0 | - | ||||
HBA1c | ≤ 7% | 7.5 ± 1.4 | 0.86 | 7.7 ± 2.2 | 0.29 | - | - |
> 7% | 7.6 ± 1.9 | 8.3 ± 1.8 | - | ||||
Age | ≤ 60 yr | 7.3 ± 1.5 | 0.32 | 8.4 ± 2.1 | 0.25 | 5.5 ± 1.2 | 0.79 |
> 60 yr | 7.9 ± 2.2 | 7.8 ± 1.8 | 5.4 ± 1.5 | ||||
Sex | Female | 7.0 ± 1.4 | 0.10 | 7.8 ± 1.7 | 0.37 | 4.9 ± 0.7 | 0.00 |
Male | 8.0 ± 2.0 | 8.3 ± 2.2 | 5.9 ± 1.6 |
Table 6 Relationship between median nerve cross-sectional area on ultrasound and clinical/laboratory parameters of the diabetic subjects
Variables | CATL | 5cmCATL | ||
r | P-value | r | P-value | |
Age | -0.041 | 0.898 | -0.050 | 0.650 |
Sex | -0.0581 | 0.601 | -0.0501 | 0.651 |
Weight | 0.094 | 0.390 | -0.041 | 0.708 |
Height | 0.042 | 0.703 | 0.025 | 0.817 |
BMI | 0.091 | 0.407 | -0.056 | 0.611 |
SBP | -0.126 | 0.251 | 0.050 | 0.648 |
DBP | 0.043 | 0.693 | 0.050 | 0.648 |
TC | 0.092 | 0.402 | 0.092 | 0.056 |
Duration of DM | 0.1102 | 0.318 | 0.1512 | 0.167 |
FBG | -0.059 | 0.591 | 0.026 | 0.811 |
HbA1c | -0.012 | 0.916 | 0.034 | 0.758 |
- Citation: Attah FA, Asaleye CM, Omisore AD, Kolawole BA, Aderibigbe AS, Alo M. Relationship between sonographically measured median nerve cross-sectional area and presence of peripheral neuropathy in diabetic subjects. World J Diabetes 2019; 10(1): 47-56
- URL: https://www.wjgnet.com/1948-9358/full/v10/i1/47.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i1.47